Replies to post #135320 on Biotech Values

[ghmm]

A company (I think they are still private) called SCYNEXIS has a webcast
http://noble.mediasite.com/mediasite/SilverlightPlayer/Default.aspx?peid=0e04597426a946268a52b0710e9c29501d

They have an HCV mechanism I never heard

http://www.scynexis.com/pipeline/scy-635-hcv-clinical-candidate/

Core SCY-635 Facts
Inhibits host cyclophilin A, a mechanism shown to completely suppress viral replication in vitro

Maybe they are preparing their IPO while the market is ripe :-)